Three years into a major public-private partnership between GlaxoSmithKline and Fiocuz, Brazil main Institutes of Health, the company estimates the transfer of technology and joint research under the agreement. GSK sells Synflorix vaccines (pediatric pneumonia) at a fixed price, even if it transferred technology and know-how to Brazil for a possible domestic production. At the same time, GSK sponsored the study of a new vaccine against dengue fever with the Brazilian government. GSK management should consider PPP provides a strategic advantage for their business products for health in Brazil and access to other emerging markets, as well as risks associated with aggressive product obsolescence is built into a technology transfer agreement. "Hide
by Arthur A. Daemmrich, Ian McKown Cornell Source: Harvard Business School 15 pages. Publication Date: June 11, 2012. Prod. #: 712049-PDF-ENG
Related Case Solutions & Analyses:
Colorscope Inc. (Abridged)
Putting It Together: How to Succeed in Distributed Product Development
Dell Computer: Business to Business Over the Web in 2001
Merrill Lynch: Integrated Choice (Abridged)
Diamond in the Rough (B)
Tong Yangs Cement (B): Demand Forecasting and Globalization
THE HARILELA ENTERPRISES
GEOPOLITICAL & GEO-ECONOMICS
Mr. Graham’s Case
STELLA Mccartney
